Wells Fargo & Company Adamis Pharmaceuticals Corp Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.1 - $0.3 $1,001 - $3,004	10,016 Added 981.0%	11,037 $1,000
Q4 2022 Feb 13, 2023	BUY	$0.14 - $0.22 $3 - $5	25 Added 2.51%	1,021 $0
Q3 2022 Nov 14, 2022	SELL	$0.24 - $0.54 $1 - $3	-6 Reduced 0.6%	996 $0
Q2 2022 Aug 12, 2022	BUY	$0.34 - $0.57 $29 - $49	86 Added 9.39%	1,002 $1,000
Q1 2022 May 16, 2022	BUY	$0.55 - $0.73 $1 - $2	3 Added 0.33%	916 $1,000

Q3 2021 Nov 15, 2021	SELL	$0.92 - $1.18 $41 - $53	-45 Reduced 4.7%	913 $1,000
Q2 2021 Aug 16, 2021	BUY	$0.66 - $1.23 $58 - $108	88 Added 10.11%	958 $1,000
Q1 2021 May 13, 2021	BUY	$0.54 - $1.79 $140 - $465	260 Added 42.62%	870 $1,000
Q4 2020 Feb 09, 2021	BUY	$0.4 - $1.01 $62 - $158	157 Added 34.66%	610 $0
Q3 2020 Nov 05, 2020	SELL	$0.52 - $1.45 $21 - $59	-41 Reduced 8.3%	453 $0
Q2 2020 Aug 13, 2020	BUY	$0.33 - $0.66 $27 - $54	82 Added 19.9%	494 $0
Q1 2020 May 14, 2020	BUY	$0.33 - $0.89 $135 - $366	412 New	412 $0

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.